Kamada Ltd.

(KMDA) Trade

By |

Profile

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing and marketing of specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX etc. The company has Proprietary products and Distribution segments. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from Proprietary products segment and generates the majority of sales from the United States. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Contact Information

Website: www.kamada.com
Email: ir@kamada.com
Main Phone: +972 89406472
Address: 2 Holzman Street
Address 2: P.O Box 4081
City / Town: Rehovot
Country: IL
Postal Code: 7670402

Issuer Information

Exchange: NGS
CEO: Amir London
Employees: 429
NAICS: Pharmaceutical P

Equities News

Profile

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing and marketing of specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX etc. The company has Proprietary products and Distribution segments. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from Proprietary products segment and generates the majority of sales from the United States. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Contact Information

Website: www.kamada.com
Email: ir@kamada.com
Main Phone: +972 89406472
Address: 2 Holzman Street
Address 2: P.O Box 4081
City / Town: Rehovot
Country: IL
Postal Code: 7670402

Issuer Information

Exchange: NGS
CEO: Amir London
Employees: 429
NAICS: Pharmaceutical P

Equities News

$ 8.98 $ 0.29 (3.34%)
Last Price 8.98 Change $ 0.29 Change % 3.34 Tick N/A
Bid 8.40 Bid Size 100.00 Ask 9.49 Ask Size 100.00
Open 8.67 High 9.04 Low 8.67 Prev Close 8.69
Last Trade Volume 141,676 52 Wk Hi 13.33 52 Wk Low 4.41
Market Cap 399.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 44,523,970.00 EPS (TTM) 0.64 PE Ratio 18.60 Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 11 11 11 11
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 8.33 8.33 8.33 8.33
Standard Deviation 2.31 2.31 2.31 2.31
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1